» Articles » PMID: 12767958

Acute Pyelonephritis in Adults: Prediction of Mortality and Failure of Treatment

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2003 May 28
PMID 12767958
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To formulate a classification tool for early recognition of patients admitted with acute pyelonephritis (AP) who are at high risk for failure of treatment or for death.

Methods: A retrospective chart review of 225 patients (102 men) admitted with AP. We considered 13 potential risk factors in a multivariate analysis.

Results: Recent hospitalization, previous use of antibiotics, and immunosuppression were found to be independent correlates of the prevalence of resistant pathogens in both sexes. Additional predictors included nephrolithiasis in women and a history of recurrent AP in men. Prolonged hospitalization should be expected for a man with diabetes and long-term catheterization who is older than 65 years or for a woman of any age with the same characteristics, when the initial treatment was changed according to the results of urine culture. For mortality prediction, we derived an integer-based scoring system with 6 points for shock, 4 for bedridden status, 4 for age greater than 65 years, and 3 for previous antibiotic treatment for men and 6 points for shock, 4 for bedridden status, 4 for age greater than 65 years, and 3 for immunosuppression for women. Among patients with at least 11 points, the risk for in-hospital death was 100% for men and 91% for women.

Conclusions: Simple variables available at presentation can be used for risk stratification of patients with AP. The additional identification of certain risk factors by means of a carefully obtained history could contribute to early recognition of patients infected by resistant bacteria and optimize the selection of antimicrobial agents.

Citing Articles

Effect of Inadequate Treatment in Adult Patients with Community-Acquired Acute Pyelonephritis Due to Enterobacterales Under Empirical Management with Cefazolin.

Nocua-Baez L, Reyes P, Cortes J Antibiotics (Basel). 2025; 14(2).

PMID: 40001440 PMC: 11851720. DOI: 10.3390/antibiotics14020197.


Effect of Inappropriate Treatment in Hospitalized Patients with Pyelonephritis Treated with Cefuroxime: A Cohort Study.

Cortes J, Sierra C, Sanchez R Antibiotics (Basel). 2024; 13(3).

PMID: 38534709 PMC: 10967530. DOI: 10.3390/antibiotics13030274.


Androgen exposure impairs neutrophil maturation and function within the infected kidney.

Hreha T, Collins C, Cole E, Jin R, Hunstad D mBio. 2024; 15(2):e0317023.

PMID: 38206009 PMC: 10865792. DOI: 10.1128/mbio.03170-23.


Analysis of Nephrolithiasis Treatment in Highest Reference Hospital-Occurrence of Acromegaly in the Study Group.

Zabkowski T, Durma A, Grabinska A, Michalczyk L, Saracyn M J Clin Med. 2023; 12(12).

PMID: 37373574 PMC: 10299108. DOI: 10.3390/jcm12123879.


Can Urinalysis and Past Medical History of Kidney Stones Predict Urine Antibiotic Resistance?.

Mohseni M, Craver E, Heckman M, Sheele J West J Emerg Med. 2022; 23(5):613-617.

PMID: 36205684 PMC: 9541996. DOI: 10.5811/westjem.2022.4.54872.